Efficient Delivery of Investigational Antibacterial Agents via Sustainable Clinical Trial Networks

Antibiotic reimbursement in a model delinked from sales: a benchmark-based worldwide approach

(2016) John H Rex et al.   LANCET INFECTIOUS DISEASES

Developing Outcomes Assessments as Endpoints for Registrational Clinical Trials of Antibacterial Drugs: 2015 Update From the Biomarkers Consortium of the Foundation for the National Institutes of Health: Table 1.

(2015) George H. Talbot et al.   CLINICAL INFECTIOUS DISEASES

The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public–private partnerships for the development of new strategies to tackle antibiotic resistance

(2015) T. Kostyanev et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A Simulation Study Evaluating Bio-Creep Risk in Serial Noninferiority Clinical Trials for Preservation of Effect

(2015) K. Odem-Davis et al.   Statistics in Biopharmaceutical Research

Managing Transmission of Carbapenem-Resistant Enterobacteriaceae in Healthcare Settings: A View From the Trenches

(2013) T. N. Palmore et al.   CLINICAL INFECTIOUS DISEASES

A comprehensive regulatory framework to address the unmet need for new antibacterial treatments

(2013) John H Rex et al.   LANCET INFECTIOUS DISEASES

International Rare Cancers Initiative

(2013) Nicola Keat et al.   LANCET ONCOLOGY